Related Experiment Video
Updated: Mar 2, 2026
09:10
DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density
Published on: July 22, 2022
3.8K
Accelerated Antidepressant Response in Geriatric Inpatients.
Robert E McCue1, Jeffrey Aronowitz1
1Department of Psychiatry, Beth Israel Medical Center, New York, NY 10003.
Summary
Low doses of nortriptyline and fluoxeline combined effectively reduced depressive symptoms in elderly patients. This accelerated antidepressant response occurred with minimal side effects, regardless of nortriptyline plasma levels.
Area of Science:
- Geriatric Psychiatry
- Pharmacology
Background:
- Depression in the elderly is a significant concern.
- Standard antidepressant treatments can have limitations in older adults.
Purpose of the Study:
- To evaluate the efficacy and safety of combined low-dose nortriptyline and fluoxetine in elderly depressed inpatients.
- To explore the relationship between plasma nortriptyline levels and clinical improvement.
Main Methods:
- A 2-week open-label study involving six elderly inpatients with depression.
- Treatment with low doses of nortriptyline and fluoxetine concurrently.
- Assessment of depressive symptoms and side effects.
Main Results:
- All six patients experienced significant reductions in depressive symptoms.
- The combination therapy was associated with minimal side effects.
- Clinical improvement was observed irrespective of achieving therapeutic plasma levels of nortriptyline.
Conclusions:
- Combined low-dose nortriptyline and fluoxetine may offer an effective and safe option for accelerated antidepressant response in elderly patients.
- Further research is warranted to confirm these findings and explore the underlying mechanisms.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
287
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
287
01:15Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
765
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
765
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
291
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
291